About Lorbrexen 100mg Tablet
Lorbrexen 100mg Tablet is a powerful medication designed to treat specific types of cancer, primarily targeting tumors associated with an abnormality in a gene called ALK (anaplastic lymphoma kinase) or ROS1 (c-ros oncogene 1). Lorbrexen 100mg Tablet contains Lorlatinib, a potent and targeted therapy that inhibits the growth and spread of cancer cells in patients with ALK-positive or ROS1-positive metastatic non-small cell lung cancer (NSCLC).
Uses Lorbrexen 100mg Tablet
- Treatment of ALK-Positive NSCLC
- Treatment of ROS1-Positive NSCLC
Benefits Of Lorbrexen 100mg Tablet
In Treatment of ALK-positive NSCLC
Lorbrexen 100mg Tablet is commonly prescribed for the treatment of metastatic non-small cell lung cancer (NSCLC) that is driven by an abnormality in the ALK (anaplastic lymphoma kinase) gene. It is particularly effective in cases where the cancer has spread to other parts of the body.
In Treatment of ROS1-positive NSCLC
Lorbrexen 100mg Tablet is also used to treat NSCLC in patients with a ROS1 (c-ros oncogene 1) gene mutation, which is another specific genetic abnormality associated with certain lung cancers.
Side Effects Of Lorbrexen 100mg Tablet
Lorbrexen 100mg Tablet, like many medications, can have side effects. It’s essential for patients to be aware of potential side effects and to discuss them with their healthcare provider.
Common side effects of Lorbrexen
- Muscle Pain
- Edema (Swelling)
- Cognitive Changes
- Nervous System Effects
- Vision Problems
- Respiratory Symptoms
- Nausea and Vomiting
- Increased Liver Enzymes
- Medical Supervision
- Patient-Specific Assessment
- Genetic Testing
- Dosage and Administration
- Side Effect Monitoring
- Liver Function
- Pregnancy and Breastfeeding
- Driving and Operating Machinery
- Avoid Alcohol
- Interactions with Other Medications